These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 29506503

  • 21. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages.
    Tanaka S, Fujita S, Kizawa S, Morita H, Ishizaka N.
    PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031
    [Abstract] [Full Text] [Related]

  • 22. [MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE].
    Milovanova LY, Kozlovskaya LV, Markina MM, Milovanova SY, Borisov AA, Mukhin NA, Fomin VV, Moiseev SV.
    Klin Med (Mosk); 2015; 93(12):32-8. PubMed ID: 27149811
    [Abstract] [Full Text] [Related]

  • 23. Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease.
    Seifert ME, de las Fuentes L, Ginsberg C, Rothstein M, Dietzen DJ, Cheng SC, Ross W, Windus D, Dávila-Román VG, Hruska KA.
    Am J Nephrol; 2014; 39(5):392-9. PubMed ID: 24818573
    [Abstract] [Full Text] [Related]

  • 24. The association between socioeconomic disparities and left ventricular hypertrophy in chronic kidney disease: results from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD).
    Kang E, Lee J, Kim HJ, Han M, Kim SW, Lee KB, Sung S, Yoo TH, Chung W, Ahn C, Oh KH.
    BMC Nephrol; 2018 Aug 16; 19(1):203. PubMed ID: 30115015
    [Abstract] [Full Text] [Related]

  • 25. Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease.
    Sakuragi S, Ichikawa K, Yamada K, Tanimoto M, Miki T, Otsuka H, Yamamoto K, Kawamoto K, Katayama Y, Tanakaya M, Ito H.
    Int J Cardiol; 2015 Aug 16; 190():287-92. PubMed ID: 25932809
    [Abstract] [Full Text] [Related]

  • 26. [Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B-4 chronic kidney disease: A new direction of cardionephroprotection].
    Milovanov YS, Mukhin NA, Kozlovskaya LV, Milovanova SY, Markina MM.
    Ter Arkh; 2016 Aug 16; 88(6):21-25. PubMed ID: 27296257
    [Abstract] [Full Text] [Related]

  • 27. Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.
    Silva AP, Mendes F, Carias E, Gonçalves RB, Fragoso A, Dias C, Tavares N, Café HM, Santos N, Rato F, Leão Neves P, Almeida E.
    Int J Mol Sci; 2019 Mar 27; 20(7):. PubMed ID: 30934737
    [Abstract] [Full Text] [Related]

  • 28. Mild chronic kidney disease associated with greater risk of arterial stiffness in elderly adults.
    Liu IT, Wu JS, Yang YC, Huang YH, Lu FH, Chang CJ.
    J Am Geriatr Soc; 2013 Oct 27; 61(10):1758-62. PubMed ID: 24083328
    [Abstract] [Full Text] [Related]

  • 29. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease: findings from the CKD-JAC study.
    Nitta K, Iimuro S, Imai E, Matsuo S, Makino H, Akizawa T, Watanabe T, Ohashi Y, Hishida A.
    Clin Exp Nephrol; 2019 Jan 27; 23(1):85-98. PubMed ID: 29951723
    [Abstract] [Full Text] [Related]

  • 30. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E, Thodis E, Arsos G, Pasadakis P, Panagoutsos S, Papadopoulou D, Papagianni A.
    Kidney Blood Press Res; 2020 Jan 27; 45(6):900-915. PubMed ID: 33040068
    [Abstract] [Full Text] [Related]

  • 31. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.
    Shimamura Y, Hamada K, Inoue K, Ogata K, Ishihara M, Kagawa T, Inoue M, Fujimoto S, Ikebe M, Yuasa K, Yamanaka S, Sugiura T, Terada Y.
    Clin Exp Nephrol; 2012 Oct 27; 16(5):722-9. PubMed ID: 22457086
    [Abstract] [Full Text] [Related]

  • 32. Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study.
    Brady TM, Roem J, Cox C, Schneider MF, Wilson AC, Furth SL, Warady BA, Mitsnefes M.
    Am J Kidney Dis; 2020 Aug 27; 76(2):166-173. PubMed ID: 32389356
    [Abstract] [Full Text] [Related]

  • 33. FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study.
    Desbiens LC, Sidibé A, Ung RV, Fortier C, Munger M, Wang YP, Bisson SK, Marquis K, Agharazii M, Mac-Way F.
    Osteoporos Int; 2018 Oct 27; 29(10):2345-2353. PubMed ID: 29959497
    [Abstract] [Full Text] [Related]

  • 34. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease.
    Liu QF, Ye JM, Yu LX, He AL, Sun Q, He DW, Li SS.
    J Investig Med; 2018 Mar 27; 66(3):669-675. PubMed ID: 29061648
    [Abstract] [Full Text] [Related]

  • 35. Association of uric acid and left ventricular mass index with renal outcomes in chronic kidney disease.
    Chen SC, Chang JM, Yeh SM, Su HM, Chen HC.
    Am J Hypertens; 2013 Feb 27; 26(2):243-9. PubMed ID: 23382409
    [Abstract] [Full Text] [Related]

  • 36. Association Between High-Sensitivity Cardiac Troponin T and Echocardiographic Parameters in Chronic Kidney Disease: Results From the KNOW-CKD Cohort Study.
    Kang E, Ryu H, Kim J, Lee J, Lee KB, Chae DW, Sung SA, Kim SW, Ahn C, Oh KH.
    J Am Heart Assoc; 2019 Sep 17; 8(18):e013357. PubMed ID: 31514574
    [Abstract] [Full Text] [Related]

  • 37. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
    Gan L, Zhou Q.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep 28; 42(9):1058-1065. PubMed ID: 28989152
    [Abstract] [Full Text] [Related]

  • 38. Risk factors associated with increased left ventricular mass index in chronic kidney disease patients evaluated using echocardiography.
    Matsumoto M, Io H, Furukawa M, Okumura K, Masuda A, Seto T, Takagi M, Sato M, Nagahama L, Omote K, Hisada A, Horikoshi S, Tomino Y.
    J Nephrol; 2012 Sep 28; 25(5):794-801. PubMed ID: 22241636
    [Abstract] [Full Text] [Related]

  • 39. Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease.
    Akimoto T, Yoshizawa H, Watanabe Y, Numata A, Yamazaki T, Takeshima E, Iwazu K, Komada T, Otani N, Morishita Y, Ito C, Shiizaki K, Ando Y, Muto S, Kuro-o M, Kusano E.
    BMC Nephrol; 2012 Nov 23; 13():155. PubMed ID: 23176706
    [Abstract] [Full Text] [Related]

  • 40. Influence of exogenous growth hormone administration on circulating concentrations of α-klotho in healthy and chronic kidney disease subjects: a prospective, single-center open case-control pilot study.
    Adema AY, de Roij van Zuijdewijn CLM, Hoenderop JG, de Borst MH, Ter Wee PM, Heijboer AC, Vervloet MG, NIGRAM consortium,.
    BMC Nephrol; 2018 Nov 15; 19(1):327. PubMed ID: 30442108
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.